California Stem Cell Agency's Business Partnering Program and BlueRock Therapeutics
A $240-million deal yesterday involved an East Coast biotech firm that has loose ties to California's nearly 15-year-old stem cell research program.
The firm is Blue Rock Therapeutics, Inc., a privately held cell therapy company based in Cambridge, Mass. Bayer owned about 60 percent of the company and picked up the remainder for $240 million in what it…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.